GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

GeneReach Biotechnology 4171.TWO · TWD

Health Care · Taipei Exchange · 🇹🇼 Taiwan

Compare

15.15

+1.00%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in TWD, from our data supplier.

FY2025

Revenue

TWD 232.7m

FY2016FY2025

Net income

−TWD 110.3m

FY2016FY2025

Free cash flow

−TWD 25.2m

FY2016FY2025

Shareholders' equity

TWD 586.7m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueTWD 232.7mTWD 206.5mTWD 225.5mTWD 750.0mTWD 1.01bnTWD 857.0mTWD 365.8mTWD 187.4mTWD 155.4mTWD 150.3m
Research and developmentTWD 72.8mTWD 80.5mTWD 61.5mTWD 58.8mTWD 56.6mTWD 68.8mTWD 41.0mTWD 29.5mTWD 33.5mTWD 34.9m
Operating income−TWD 86.9m−TWD 135.9m−TWD 191.2mTWD 277.9mTWD 480.7mTWD 344.8mTWD 113.9mTWD 11.4m−TWD 40.0m−TWD 26.7m
Net income−TWD 110.3m−TWD 118.7m−TWD 166.3mTWD 221.3mTWD 376.6mTWD 257.3mTWD 77.2mTWD 28.6m−TWD 48.1m−TWD 38.7m
Diluted earnings per share-1.92-2.07-2.883.859.016.161.340.50-0.84-0.78

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsTWD 881.1mTWD 1.07bnTWD 1.18bnTWD 1.62bnTWD 1.68bnTWD 1.24bnTWD 760.9mTWD 693.8mTWD 602.8mTWD 554.4m
Cash and short-term investments——TWD 531.9mTWD 764.0mTWD 677.3mTWD 356.4m———TWD 131.2m
Total liabilitiesTWD 284.3mTWD 341.0mTWD 313.7mTWD 519.2mTWD 596.3mTWD 382.7mTWD 167.8mTWD 382.7mTWD 352.2mTWD 248.7m
Debt——TWD 257.0mTWD 402.5mTWD 394.6mTWD 207.3m———TWD 206.5m
Shareholders' equityTWD 586.7mTWD 717.0mTWD 832.1mTWD 1.07bnTWD 1.05bnTWD 813.0mTWD 555.5mTWD 288.8mTWD 250.6mTWD 305.7m
Shares outstanding57m57m58m57m42m42m57m57m57m49m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−TWD 13.5m−TWD 23.2m−TWD 38.7mTWD 357.6mTWD 349.0mTWD 169.8m−TWD 11.2mTWD 5.7m−TWD 6.8mTWD 5.2m
Capital spending−TWD 11.6m−TWD 8.5m−TWD 27.4m−TWD 44.9m−TWD 15.8m−TWD 64.9m−TWD 13.5m−TWD 2.3m−TWD 895,000−TWD 4.7m
Free cash flow−TWD 25.2m−TWD 31.7m−TWD 66.0mTWD 312.7mTWD 333.2mTWD 104.9m−TWD 24.7mTWD 3.4m−TWD 7.7mTWD 439,000
Dividends paid—−TWD 16.0m−TWD 68.9m−TWD 208.9m−TWD 143.7m−TWD 143.7m−TWD 143.7m−TWD 143.7m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueTWD 60.0mTWD 52.3mTWD 72.4mTWD 53.4mTWD 54.5mTWD 52.5mTWD 55.0mTWD 62.5m
Operating income−TWD 9.6m−TWD 14.7m−TWD 1.0m−TWD 36.5m−TWD 26.0m−TWD 25.9m−TWD 26.9m−TWD 27.2m
Net income−TWD 3.9m−TWD 5.4mTWD 2.8m−TWD 36.6m−TWD 66.1m−TWD 10.3m−TWD 35.4m−TWD 26.9m
Diluted earnings per share-0.07-0.090.05-0.64-1.15-0.18-0.62-0.47
Cash from operationsTWD 6.0m−TWD 2.0mTWD 12.0m−TWD 2.0m−TWD 22.0m—−TWD 5.0m−TWD 9.0m
Capital spending−TWD 8.0m—−TWD 4.0m−TWD 2.0m−TWD 1.0m−TWD 3.0m−TWD 1.0m−TWD 1.0m
Free cash flow−TWD 2.0m—TWD 8.0m−TWD 4.0m−TWD 23.0m—−TWD 6.0m−TWD 10.0m
Total assetsTWD 858.1mTWD 864.6mTWD 881.1mTWD 877.5mTWD 947.0mTWD 1.05bnTWD 1.07bnTWD 1.09bn
Shareholders' equityTWD 572.7mTWD 583.6mTWD 586.7mTWD 581.8mTWD 614.6mTWD 703.3mTWD 717.0mTWD 751.2m

Financial ratios

Data as of 5 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2017
Operating margin-47.2%-53.8%-84.8%37.0%47.5%40.2%—
Net margin-47.4%-57.5%-73.7%29.5%37.2%30.0%—
Return on equity-18.8%-16.6%-20.0%20.7%35.9%31.6%—
Return on assets-12.5%-11.1%-14.1%13.6%22.4%20.7%—
Free cash flow yield—-1.6%-1.2%44.6%55.6%35.8%—
Revenue growth12.7%-8.4%-69.9%-25.9%18.1%134.3%—
Earnings growth-7.1%-28.6%-175.1%-41.2%46.4%233.4%—
Current ratio2.41x2.48x3.07x2.78x4.24x3.26x—
Debt to equity——0.19x0.27x0.29x0.13x0.00x
Equity ratio66.6%67.2%70.7%65.8%62.3%65.5%—
Interest coverage-16.90x-18.71x-33.17x42.02x76.75x90.32x—
R&D as a share of sales31.3%39.0%27.3%7.8%5.6%8.0%—
Buybacks as a share of market value—0.4%-0.4%-37.5%0.0%——

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-32.3%-22.9%4.6%
Operating income——12.4%
Net income——16.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-50.7%-9.6%21.0%16.8%
Net margin-52.1%-12.3%14.0%10.6%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-9.8-13.9-13.713.77.314.935.554.8-16.5-18.0
Price to sales4.68.010.14.02.74.57.58.45.14.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 28 Jul 2023.

FY2023FY2022
Paid in the year1.504.00
  • 1250-for-1000 split · 28 Jul 2023
  • 1100-for-1000 split · 13 Sept 2022
  • 1029.496-for-1000 split · 7 Oct 2021

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.